Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease C Besler, K Heinrich, L Rohrer, C Doerries, M Riwanto, DM Shih, A Chroni, ... The Journal of clinical investigation 121 (7), 2693-2708, 2011 | 654 | 2011 |
A SIRT7-dependent acetylation switch of GABPβ1 controls mitochondrial function D Ryu, YS Jo, GL Sasso, S Stein, H Zhang, A Perino, JU Lee, M Zeviani, ... Cell metabolism 20 (5), 856-869, 2014 | 274 | 2014 |
Protective roles of SIRT1 in atherosclerosis S Stein, CM Matter Cell cycle 10 (4), 640-647, 2011 | 272 | 2011 |
SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis S Stein, C Lohmann, N Schäfer, J Hofmann, L Rohrer, C Besler, ... European heart journal 31 (18), 2301-2309, 2010 | 252 | 2010 |
TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation A Perino, TWH Pols, M Nomura, S Stein, R Pellicciari, K Schoonjans The Journal of clinical investigation 124 (12), 5424-5436, 2014 | 206 | 2014 |
SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/-mice S Stein, N Schäfer, A Breitenstein, C Besler, S Winnik, C Lohmann, ... Aging (Albany NY) 2 (6), 353, 2010 | 197 | 2010 |
Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrol AG Rajapakse, G Yepuri, JM Carvas, S Stein, CM Matter, I Scerri, ... PloS one 6 (4), e19237, 2011 | 165 | 2011 |
Mouse models for atherosclerosis research—which is my line? S Oppi, TF Lüscher, S Stein Frontiers in cardiovascular medicine 6, 46, 2019 | 162 | 2019 |
Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease K Gariani, D Ryu, KJ Menzies, HS Yi, S Stein, H Zhang, A Perino, ... Journal of hepatology 66 (1), 132-141, 2017 | 160 | 2017 |
The Sirt1 activator SRT3025 provides atheroprotection in Apoe−/− mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression MX Miranda, LJ Van Tits, C Lohmann, T Arsiwala, S Winnik, A Tailleux, ... European heart journal 36 (1), 51-59, 2015 | 151 | 2015 |
Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells A Breitenstein, S Stein, EW Holy, GG Camici, C Lohmann, A Akhmedov, ... Cardiovascular research 89 (2), 464-472, 2011 | 128 | 2011 |
Heart-Infiltrating Prominin-1+/CD133+ Progenitor Cells Represent the Cellular Source of Transforming Growth Factor β–Mediated Cardiac Fibrosis in Experimental … G Kania, P Blyszczuk, S Stein, A Valaperti, D Germano, S Dirnhofer, ... Circulation research 105 (5), 462-470, 2009 | 124 | 2009 |
Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo A Akhmedov, I Rozenberg, F Paneni, GG Camici, Y Shi, C Doerries, ... European heart journal 35 (40), 2839-2848, 2014 | 112 | 2014 |
SUMOylation-dependent LRH-1/PROX1 interaction promotes atherosclerosis by decreasing hepatic reverse cholesterol transport S Stein, MH Oosterveer, C Mataki, P Xu, V Lemos, R Havinga, C Dittner, ... Cell metabolism 20 (4), 603-613, 2014 | 91 | 2014 |
Role of TGR5 (GPBAR1) in liver disease V Keitel, D Häussinger Seminars in liver disease 38 (04), 333-339, 2018 | 88 | 2018 |
Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets C Lohmann, N Schäfer, T von Lukowicz, MA Sokrates Stein, J Borén, ... Atherosclerosis 207 (2), 360-367, 2009 | 88 | 2009 |
Neutrophils in cardiovascular disease DS Gaul, S Stein, CM Matter European heart journal 38 (22), 1702-1704, 2017 | 87 | 2017 |
Radiologic studies in acute fatty liver of pregnancy. A review of the literature and 19 new cases. MA Castro, JG Ouzounian, PM Colletti, KJ Shaw, SM Stein, TM Goodwin The Journal of Reproductive Medicine 41 (11), 839-843, 1996 | 81 | 1996 |
LRH-1-dependent programming of mitochondrial glutamine processing drives liver cancer P Xu, MH Oosterveer, S Stein, H Demagny, D Ryu, N Moullan, X Wang, ... Genes & development 30 (11), 1255-1260, 2016 | 79 | 2016 |
SIRT1-an anti-inflammatory pathway at the crossroads between metabolic disease and atherosclerosis S Winnik, S Stein, C M Matter Current vascular pharmacology 10 (6), 693-696, 2012 | 79 | 2012 |